| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $118.4M | -0.5% |
| SG&A Expense | $60.6M | +2.4% |
| Operating Income | -$179.0M | -0.5% |
| Interest Expense | $4.5M | +0.0% |
| Pre-tax Income | -$290.3M | -89.1% |
| Income Tax | -$2.5M | -255.1% |
| Net Income | -$287.9M | -85.6% |
| EPS (Basic) | -$3.08 | -33.9% |
| EPS (Diluted) | -$3.08 | -33.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $149.6M | -9.4% |
| Current Assets | $191.5M | -4.9% |
| Total Assets | $210.3M | -1.6% |
| Current Liabilities | $247.8M | +628.5% |
| Long-term Debt | $31.6M | +4.9% |
| Total Liabilities | $263.2M | +346.3% |
| Stockholders' Equity | -$52.8M | -134.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$157.2M | -31.9% |
| Financing Cash Flow | $140.7M | +120.5% |